New Predictive Biomarkers for Ovarian Cancer
Ovarian cancer is the eighth-most common cause of death among women worldwide. In the absence of distinctive symptoms in the early stages, the majority of women are diagnosed in advanced stages of the disease. Surgical debulking and systemic adjuvant chemotherapy remain the mainstays of treatment, w...
Main Authors: | Ghofraan Abdulsalam Atallah, Nor Haslinda Abd. Aziz, Chew Kah Teik, Mohamad Nasir Shafiee, Nirmala Chandralega Kampan |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/11/3/465 |
Similar Items
-
Where are we going with sentinel nodes mapping in ovarian cancer?
by: Nirmala Chandralega Kampan, et al.
Published: (2022-11-01) -
Prognostic Value of TNFR2 and STAT3 among High-Grade Serous Ovarian Cancer Survivors According to Platinum Sensitivity
by: Janisha Silva Raju, et al.
Published: (2021-03-01) -
Unlocking ovarian cancer heterogeneity: advancing immunotherapy through single-cell transcriptomics
by: Dharvind Balan, et al.
Published: (2024-05-01) -
Interleukin 6 Present in Inflammatory Ascites from Advanced Epithelial Ovarian Cancer Patients Promotes Tumor Necrosis Factor Receptor 2-Expressing Regulatory T Cells
by: Nirmala Chandralega Kampan, et al.
Published: (2017-11-01) -
Identification of comutation in signaling pathways to predict the clinical outcomes of immunotherapy
by: Jiayue Qiu, et al.
Published: (2022-12-01)